UBS Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.57M | Sell |
501,084
-945,374
| -65% | -$16.2M | ﹤0.01% | 2556 |
|
|
2025
Q1 | $92.3M | Sell |
1,446,458
-33,540
| -2% | -$2.14M | 0.02% | 786 |
|
|
2024
Q4 | $180M | Buy |
1,479,998
+1,115,826
| +306% | +$136M | 0.03% | 456 |
|
|
2024
Q3 | $45.5M | Buy |
364,172
+13,408
| +4% | +$1.67M | 0.01% | 867 |
|
|
2024
Q2 | $55.4M | Buy |
350,764
+73,574
| +27% | +$11.6M | 0.01% | 724 |
|
|
2024
Q1 | $35.9M | Buy |
277,190
+914
| +0.3% | +$118K | 0.01% | 907 |
|
|
2023
Q4 | $26.6M | Buy |
276,276
+48,405
| +21% | +$4.67M | 0.01% | 965 |
|
|
2023
Q3 | $27.6M | Buy |
227,871
+11,531
| +5% | +$1.4M | 0.01% | 872 |
|
|
2023
Q2 | $24.8M | Buy |
216,340
+21,918
| +11% | +$2.51M | 0.01% | 941 |
|
|
2023
Q1 | $26.8M | Buy |
194,422
+31,742
| +20% | +$4.38M | 0.01% | 859 |
|
|
2022
Q4 | $21.1M | Buy |
162,680
+91,942
| +130% | +$11.9M | 0.01% | 970 |
|
|
2022
Q3 | $7.82M | Sell |
70,738
-46,200
| -40% | -$5.11M | ﹤0.01% | 1433 |
|
|
2022
Q2 | $8.77M | Sell |
116,938
-35,935
| -24% | -$2.69M | ﹤0.01% | 1410 |
|
|
2022
Q1 | $11.9M | Buy |
152,873
+90,229
| +144% | +$7.05M | ﹤0.01% | 1344 |
|
|
2021
Q4 | $5.64M | Buy |
62,644
+15,913
| +34% | +$1.43M | ﹤0.01% | 1992 |
|
|
2021
Q3 | $4.32M | Buy |
46,731
+12,796
| +38% | +$1.18M | ﹤0.01% | 2136 |
|
|
2021
Q2 | $2.64M | Sell |
33,935
-53,265
| -61% | -$4.14M | ﹤0.01% | 2511 |
|
|
2021
Q1 | $6.5M | Buy |
87,200
+15,450
| +22% | +$1.15M | ﹤0.01% | 1741 |
|
|
2020
Q4 | $12.2M | Buy |
71,750
+4,895
| +7% | +$835K | ﹤0.01% | 1276 |
|
|
2020
Q3 | $9.39M | Buy |
66,855
+1,990
| +3% | +$279K | ﹤0.01% | 1319 |
|
|
2020
Q2 | $10.4M | Sell |
64,865
-18,799
| -22% | -$3.01M | ﹤0.01% | 1158 |
|
|
2020
Q1 | $8.18M | Sell |
83,664
-3,315
| -4% | -$324K | ﹤0.01% | 1208 |
|
|
2019
Q4 | $11.2M | Sell |
86,979
-108,252
| -55% | -$14M | ﹤0.01% | 1424 |
|
|
2019
Q3 | $14.7M | Buy |
195,231
+85,870
| +79% | +$6.47M | 0.01% | 1155 |
|
|
2019
Q2 | $16.6M | Buy |
109,361
+28,958
| +36% | +$4.4M | 0.01% | 1075 |
|
|
2019
Q1 | $9.58M | Sell |
80,403
-4,472
| -5% | -$533K | ﹤0.01% | 1378 |
|
|
2018
Q4 | $9.26M | Buy |
84,875
+22,929
| +37% | +$2.5M | ﹤0.01% | 1280 |
|
|
2018
Q3 | $10M | Sell |
61,946
-28,870
| -32% | -$4.66M | ﹤0.01% | 1416 |
|
|
2018
Q2 | $12M | Sell |
90,816
-17,148
| -16% | -$2.27M | 0.01% | 1259 |
|
|
2018
Q1 | $8M | Buy |
107,964
+29,550
| +38% | +$2.19M | ﹤0.01% | 1513 |
|
|
2017
Q4 | $4.36M | Sell |
78,414
-56,400
| -42% | -$3.14M | ﹤0.01% | 1950 |
|
|
2017
Q3 | $6.12M | Buy |
134,814
+35,317
| +35% | +$1.6M | ﹤0.01% | 1600 |
|
|
2017
Q2 | $3.35M | Buy |
99,497
+18,053
| +22% | +$609K | ﹤0.01% | 1986 |
|
|
2017
Q1 | $2.41M | Sell |
81,444
-11,529
| -12% | -$341K | ﹤0.01% | 2203 |
|
|
2016
Q4 | $2.55M | Sell |
92,973
-21,167
| -19% | -$581K | ﹤0.01% | 2089 |
|
|
2016
Q3 | $7.01M | Sell |
114,140
-332,947
| -74% | -$20.4M | ﹤0.01% | 1303 |
|
|
2016
Q2 | $8.53M | Buy |
447,087
+348,081
| +352% | +$6.64M | 0.01% | 1151 |
|
|
2016
Q1 | $1.93M | Sell |
99,006
-88,019
| -47% | -$1.72M | ﹤0.01% | 2161 |
|
|
2015
Q4 | $7.22M | Buy |
187,025
+96,871
| +107% | +$3.74M | ﹤0.01% | 1279 |
|
|
2015
Q3 | $2.9M | Sell |
90,154
-34,824
| -28% | -$1.12M | ﹤0.01% | 1883 |
|
|
2015
Q2 | $3.8M | Buy |
124,978
+42,665
| +52% | +$1.3M | ﹤0.01% | 1821 |
|
|
2015
Q1 | $1.09M | Sell |
82,313
-8,104
| -9% | -$108K | ﹤0.01% | 2728 |
|
|
2014
Q4 | $1.31M | Buy |
+90,417
| New | +$1.31M | ﹤0.01% | 2570 |
|